Update on the use of direct oral anticoagulants for the prevention and treatment of thromboembolism

被引：0

作者：

Jacobs, Anna ^{[1
,2
]}

Kabra, Rajesh ^{[3
]}

Das, Pranab ^{[4
]}

Oliphant, Carrie S. ^{[1
,2
]}

机构：

[1] Methodist Univ Hosp, Dept Pharm, 1265 Union Ave, Memphis, TN 38104 USA

[2] Univ Tennessee, Coll Pharm, Dept Clin Pharm, 920 Madison Ave, Memphis, TN 38163 USA

[3] Univ Tennessee, Hlth Sci Ctr, Div Cardiol, 1325 Eastmoreland Ave Suite 460, Memphis, TN 38104 USA

[4] St Francis Cardiol Associates, 6005 Pk Ave,Suite500 B, Memphis, TN 38119 USA

来源：

FUTURE CARDIOLOGY | 2018年 / 14卷 / 01期

关键词：

apixaban; atrial fibrillation; betrixaban; dabigatran; edoxaban; review; rivaroxaban; venous thromboembolism;

D O I：

10.2217/fca-2017-0045

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Following publication of our review article 4 years ago, there has been an uptake in the use of nonvitamin K oral antagonists, also known as direct oral anticoagulants. The most recent Xa inhibitors to receive approval are edoxaban, which has been approved for use in both atrial fibrillation and venous thromboembolism prevention and betrixaban, which has been approved in the USA for extended thromboprophylaxis in the medically ill population. Additional analyses of certain types of atrial fibrillation patients have now become available. Ongoing prescriber vigilance is recommended as additional information continues to emerge with this class of medications. The purpose of this paper is to provide an update on the use of the direct oral anticoagulant agents for the prevention and treatment of thromboembolism.

引用

下载

页码：89 / 99

页数：11

共 50 条

[1] Use of the Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism
Riva, Nicoletta
Ageno, Walter
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (05) : 1035 - +
[2] Direct Oral Anticoagulants and Their Use in Treatment and Secondary Prevention of Acute Symptomatic Venous Thromboembolism
Granziera, Serena
Hasan, Arjumand
Cohen, Alexander T.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (03) : 209 - 221
[3] Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
Song, Andrew B.
Rosovsky, Rachel P.
Connors, Jean M.
Al-Samkari, Hanny
VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 175 - 186
[4] Novel oral anticoagulants for the prevention and treatment of thromboembolism
Oliphant, Carrie S.
Jacobs, Anna
Kabra, Rajesh
Das, Pranab
FUTURE CARDIOLOGY, 2013, 9 (06) : 849 - 861
[5] The use of direct oral anticoagulants for the treatment of venous thromboembolism in patients with gynecologic malignancies
Perkins, V.
Buechel, M.
Toal, C.
Gunderson, C. C.
Zhao, D.
Moore, K. N.
Holman, L. L.
GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 191 - 191
[6] Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
I. García-Escobar
E. Brozos-Vázquez
D. Gutierrez Abad
V. Martínez-Marín
V. Pachón
A. J. Muñoz Martín
Clinical and Translational Oncology, 2021, 23 : 1034 - 1046
[7] The use of direct oral anticoagulants in the treatment of acute venous thromboembolism in cancer patients
Abdel-Razeq, Hikmat
Finianos, Antoine
Taher, Ali T.
EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (06) : 487 - 494
[8] Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
Garcia-Escobar, I.
Brozos-Vazquez, E.
Gutierrez Abad, D.
Martinez-Marin, V.
Pachon, V.
Munoz Martin, A. J.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (06): : 1034 - 1046
[9] Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Obesity
Hattaway, Quinn
Starr, Jessica A.
Pinner, Nathan A.
JOURNAL OF PHARMACY TECHNOLOGY, 2023, 39 (06) : 269 - 273
[10] Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
Nakamura, Mashio
Yamada, Norikazu
Ito, Masaaki
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (06) : 560 - 565

← 1 2 3 4 5 →